Skip to main content
Premium Trial:

Request an Annual Quote

Baird Venture Partners Raises $90 Million VC Fund

NEW YORK, Aug. 13 (GenomeWeb News) - Baird Venture Partners of Milwaukee, Wisc., announced yesterday an investment of $30 million by the pension fund SWIB (State of Wisconsin Investment Board), and the second closing on a $90 million pool of capital for investment in regional ventures including life sciences and healthcare. 

   

The firm already holds investments in microarray-and-services provider NimbleGen Systems of Madison, Wisc., and  TomoTherapy, also of Madison, as well as investments in firms in Texas, California, and Illinois.

   

New BVP investors include, among others, The State of Wisconsin Investment Board (SWIB), Wisconsin Alumni Research Foundation (WARF), Lurie Investments Inc., The Northwestern Mutual Life Insurance Company, Johnson Financial Group, the Helen Bader Trusts, Robert W. Baird & Co., and a group of angel investors.

 

 

 

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.